The Inhibition of miR-873 Provides Therapeutic Benefit in a Lipopolysaccharide-Induced Neuroinflammatory Model of Parkinson's Disease.
- Resource Type
- Article
- Source
- Oxidative Medicine & Cellular Longevity; 7/16/2020, p1-19, 19p
- Subject
- Language
- ISSN
- 19420900